Successful treatment with cladribine in a patient with Rosai-Dorfman disease complicated by severe, prolonged marrow aplasia

Leuk Lymphoma. 2024 Apr 12:1-6. doi: 10.1080/10428194.2024.2340058. Online ahead of print.

Authors

Tadeusz Robak^{1

2}, Marcin Braun³, Anna Guminska⁴, Elżbieta Iskierka-Jażdżewska^{1

2}, Paweł Robak^{1

5}

Affiliations

¹ Department of Hematology, Medical University of Lodz, Lodz, Poland.
² Department of General Hematology, Copernicus Memorial Hospital, Lodz, Poland.
³ Department of Pathology, Medical University of Lodz, Lodz, Poland.
⁴ Department of Nuclear Medicine, Copernicus Memorial Hospital, Lodz, Poland.
⁵ Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Poland.

PMID: 38608253
DOI: 10.1080/10428194.2024.2340058

No abstract available

Keywords: 2-chlorodeoxyadenosine; Rosai–Dorfman disease; cladribine; recurrent; refractory; sinus histiocytosis.